ReviewMedical oncology (Northwood, London, England)2011
An eight-year snapshot of geospatial cancer research (2002-2009): clinico-epidemiological and methodological findings and trends.
Review in Medical oncology (Northwood, London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda.Journal of global health · 2022Article
- Blood levels of endocrine-disrupting metals and prevalent breast cancer among US women.Medical oncology (Northwood, London, England) · 2019Article
- Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.Journal of the National Comprehensive Cancer Network : JNCCN · 2019Article
- Ambient air emissions of polycyclic aromatic hydrocarbons and female breast cancer incidence in US.Medical oncology (Northwood, London, England) · 2018Article
- Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.Thyroid : official journal of the American Thyroid Association · 2015Article
- Missed opportunities: racial and neighborhood socioeconomic disparities in emergency colorectal cancer diagnosis and surgery.BMC cancer · 2014Article
- Utilizing spatial statistics to identify cancer hot spots: a surveillance strategy to inform community-engaged outreach efforts.International journal of health geographics · 2014Article
- Who does not receive treatment for cancer?Journal of oncology practice · 2013Article
- Cancer mortality inequalities in urban areas: a Bayesian small area analysis in Spanish cities.International journal of health geographics · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Geographic information systems (GIS) offer a very rich toolbox of methods and technologies, and powerful research tools that extend far beyond the mere production of maps, making it possible to cross-link and study the complex interaction of disease data and factors originating from a wide range of disparate sources. Despite their potential indispensable role in cancer prevention and control programmes, GIS are underrepresented in specialised oncology literature. The latter has provided an impetus for the current review. The review provides an eight-year snapshot of geospatial cancer research in peer-reviewed literature (2002-2009), presenting the clinico-epidemiological and methodological findings and trends in the covered corpus (93 papers). The authors concluded that understanding the relationship between location and cancer/cancer care services can play a crucial role in disease control and prevention, and in better service planning, and appropriate resource utilisation. Nevertheless, there are still barriers that hinder the wide-scale adoption of GIS and related technologies in everyday oncology practice.
Indexed as
Identifiers
20589539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.